Investment Banking & Brokerage

Midway through trading Thursday, the Dow traded up 0.16 percent to 21,208.00 while the NASDAQ climbed 0.22 percent to 6,311.34. The S&P also rose, gaining 0.07 percent to 2,434.71. Leading and Lagging Sectors Financial sector was the top gainer in the US market on Thursday. Top gainers in the...

Toward the end of trading Thursday, the Dow traded up 0.29 percent to 20,721.07 while the NASDAQ rose 0.17 percent to 5,831.32. The S&P also rose, gaining 0.22 percent to 2,353.52. Leading and Lagging Sectors Thursday afternoon, the financial sector proved to be a source of strength for the...

Following the market opening Thursday, the Dow traded up 0.02 percent to 20,666.07 while the NASDAQ fell 0.03 percent to 5,820.06. The S&P also rose, gaining 0.05 percent to 2,349.65. Leading and Lagging Sectors Thursday morning, the financial sector proved to be a source of strength for the...

Toward the end of trading Friday, the Dow traded up 0.85 percent to 20,054.12 while the NASDAQ climbed 0.41 percent to 5,659.25. The S&P also rose, gaining 0.66 percent to 2,295.83. Leading and Lagging Sectors Financial shares rose by 1.42 percent in trading on Friday. Meanwhile, top...

Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it has entered into a securities purchase agreement with David Davidovich, a venture capital investor, for the sale of 6,459,948 unregistered common shares at a price of $3.87 per share for an aggregate of $25 million. The offering...

Inventergy Global, Inc. (NASDAQ: INVT) ("Inventergy"), today announced that it has entered into definitive agreements with several institutional investors and accredited investors to purchase a total of $2.15 million of common stock of the Company, consisting of 4,673,914 shares of common stock at...

Gladstone Investment Corporation (Nasdaq: GAIN) (the "Company") today announced that it plans to sell 3,000,000 shares of common stock in an underwritten public offering. The Company also plans to grant the underwriters a 30-day option to purchase additional shares of common stock on the same terms...

Oxford Lane Capital Corp. (the "Company") (NASDAQ: OXLC) (NASDAQ: OXLCP) (NASDAQ: OXLCO) and (NASDAQ: OXLCN) today announced that it plans to offer shares of its Series 2024 Term Preferred Shares (the "Preferred Stock") in an underwritten public offering. The public offering price and other terms...

AR Capital Acquisition Corp. (the "Company") announced the closing of its previously-announced initial public offering of 24,000,000 units at an offering price of $10.00 per unit. The Company's units are listed on the Nasdaq Capital Market under the trading symbol "AUMAU." Each unit consists of one...

Orchid Island Capital, Inc. (the "Company") (NYSE: ORC) announced today that it has commenced a public offering of 4,000,000 shares of its common stock. The Company also plans to grant the underwriters a 30-day option to purchase up to an additional 600,000 shares of common stock on the same terms...

Mandalay Digital Group, Inc. and its subsidiaries (Nasdaq: MNDL) (collectively, "Mandalay Digital" or "the Company"), today announced its intention, subject to market and other conditions, to commence a public offering of its common stock. Mandalay Digital intends to use the net proceeds from the...

DS Healthcare Group (Nasdaq: DSKX) today announced that it entered and consummated a securities purchase agreement with an accredited investor for the sale of 1,512,500 shares of the Company's common stock, with gross proceeds of $2,420,0000.  Ladenburg Thalmann & Co. Inc., a subsidiary of...

Securities America Inc., a subsidiary of Ladenburg Thalmann Financial Services Inc. (NYSE: LTS), is pleased to announce the addition of the independent branch Clements Investment Group LLC of Durango, Colo. Formerly with United Planners Financial Services, Clements Group has approximately $1.1...

Teva Pharmaceuticals (NYSE: TEVA) spiked almost $1 higher around 1pm on Friday after the company announced that Dr. Phillip Frost purchased one million Teva American Depositary Shares. Dr. Frost is the Chairman of the Board of Directors at Teva and made his purchase at various prices on Wednesday,...

Dr. Phillip Frost is a pharmaceutical entrepreneur and current CEO at Opko Health (NYSE: OPK). The self-made billionaire is known for his investments in ChromaDex Corp (OTC: CDXC), Teva Pharmaceutical Industries (NASDAQ: TEVA), and Ivax Corporation, which he sold to Teva. Dr. Frost serves as the...